| Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study A Iranzo, E Tolosa, E Gelpi, JL Molinuevo, F Valldeoriola, M Serradell, ... The Lancet Neurology 12 (5), 443-453, 2013 | 807 | 2013 |
| Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions VM Van Deerlin, PMA Sleiman, M Martinez-Lage, A Chen-Plotkin, ... Nature genetics 42 (3), 234-239, 2010 | 625 | 2010 |
| Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients A Iranzo, A Fernández-Arcos, E Tolosa, M Serradell, JL Molinuevo, ... PloS one 9 (2), e89741, 2014 | 606 | 2014 |
| The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ... Alzheimer's & Dementia 7 (4), 386-395. e6, 2011 | 438 | 2011 |
| A Pan‐European Study of the C9orf72 Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability, and Intermediate Repeats J van der Zee, I Gijselinck, L Dillen, T Van Langenhove, J Theuns, ... Human mutation 34 (2), 363-373, 2013 | 337 | 2013 |
| Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study KM Moore, J Nicholas, M Grossman, CT McMillan, DJ Irwin, L Massimo, ... The Lancet Neurology 19 (2), 145-156, 2020 | 281 | 2020 |
| Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease P Podlesniy, J Figueiro‐Silva, A Llado, A Antonell, R Sanchez‐Valle, ... Annals of neurology 74 (5), 655-668, 2013 | 220 | 2013 |
| Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder A Iranzo, J Santamaría, F Valldeoriola, M Serradell, M Salamero, C Gaig, ... Annals of neurology 82 (3), 419-428, 2017 | 195 | 2017 |
| Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer's disease cerebrospinal fluid A Lleó, R Núñez-Llaves, D Alcolea, C Chiva, D Balateu-Paños, ... Molecular & Cellular Proteomics 18 (3), 546-560, 2019 | 186 | 2019 |
| Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study EL van der Ende, LH Meeter, JM Poos, JL Panman, LC Jiskoot, ... The Lancet Neurology 18 (12), 1103-1111, 2019 | 170 | 2019 |
| Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers J Fortea, R Sala-Llonch, D Bartrés-Faz, B Bosch, A Llado, N Bargallo, ... Journal of Alzheimer's Disease 22 (3), 909-922, 2010 | 168 | 2010 |
| Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease M Balasa, E Gelpi, A Antonell, MJ Rey, R Sanchez-Valle, JL Molinuevo, ... Neurology 76 (20), 1720-1725, 2011 | 162 | 2011 |
| Plasma miR-34a-5p and miR-545-3p as early biomarkers of Alzheimer’s disease: potential and limitations M Cosín-Tomás, A Antonell, A Lladó, D Alcolea, J Fortea, M Ezquerra, ... Molecular neurobiology 54, 5550-5562, 2017 | 158 | 2017 |
| Memantine: targeting glutamate excitotoxicity in Alzheimer's disease and other dementias JL Molinuevo, A Lladó, L Rami American Journal of Alzheimer's Disease & Other Dementias® 20 (2), 77-85, 2005 | 154 | 2005 |
| TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions MD Gallagher, E Suh, M Grossman, L Elman, L McCluskey, ... Acta neuropathologica 127, 407-418, 2014 | 150 | 2014 |
| Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia O Dols-Icardo, A García-Redondo, R Rojas-García, R Sánchez-Valle, ... Human molecular genetics 23 (3), 749-754, 2014 | 146 | 2014 |
| Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration AS Chen-Plotkin, M Martinez-Lage, PMA Sleiman, W Hu, R Greene, ... Archives of neurology 68 (4), 488-497, 2011 | 146 | 2011 |
| Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease A Antonell, A Mansilla, L Rami, A Lladó, A Iranzo, J Olives, M Balasa, ... Journal of Alzheimer's Disease 42 (3), 901-908, 2014 | 133 | 2014 |
| Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease M Pera, D Alcolea, R Sánchez-Valle, C Guardia-Laguarta, ... Acta Neuropathologica 125, 201-213, 2013 | 129 | 2013 |
| Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study C Pottier, X Zhou, RB Perkerson, M Baker, GD Jenkins, DJ Serie, ... The Lancet Neurology 17 (6), 548-558, 2018 | 127 | 2018 |
